GlaxoSmithKline Plc (GSK) - Financial and Strategic SWOT Analysis Review

  • ID: 1291554
  • SWOT Analysis
  • 83 pages
  • GlobalData
  • GlaxoSmithKline PLC
1 of 5

FEATURED COMPANIES

  • AbbVie Inc
  • Amgen Inc
  • AstraZeneca Plc
  • Bristol-Myers Squibb Co
  • Eli Lilly and Co
  • F. Hoffmann-La Roche Ltd
  • MORE
GlaxoSmithKline Plc (GSK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

GlaxoSmithKline Plc (GSK) is a healthcare company, which focuses on the development, manufacture and commercialization of pharmaceuticals, vaccines and consumer healthcare products. It offers drugs for the treatment of HIV, respiratory, cancer, immuno-inflammation, anti-virals, central nervous system (CNS), metabolic, cardiovascular and urogenital, anti-bacterials, dermatology and rare diseases. The company offers over-the-counter (OTC) products for pain relief, oral health, nutrition, skin health and gastro-intestinal diseases. GSK’s vaccine portfolio cover various diseases including hepatitis, diphtheria, tetanus, whooping cough, rotavirus and HPV infections, measles and bacterial meningitis, among others. The company sells its products through wholesalers, pharmacies, hospitals, physicians and other groups worldwide. GSK is headquartered in Brentford, Middlesex, the UK.

GlaxoSmithKline Plc Key Recent Developments

Mar 23, 2018: GSK Update Regarding Pfizer Consumer Healthcare
Mar 19, 2018: The Pistoia Alliance Calls for Greater Life Sciences Collaboration to Build the ‘Lab of the Future’
Mar 05, 2018: Local nonprofits make a bigger IMPACT with $40,000 award from GSK in the Triangle region of North Carolina
Mar 05, 2018: Local nonprofits make a bigger IMPACT with $40,000 award from GSK in Greater Philadelphia region
Feb 23, 2018: GSK, Ministry of Economy, Trade and Industry "Superior Health and Good Management Act 2018 (White 500)" for 2 consecutive years certified

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • AbbVie Inc
  • Amgen Inc
  • AstraZeneca Plc
  • Bristol-Myers Squibb Co
  • Eli Lilly and Co
  • F. Hoffmann-La Roche Ltd
  • MORE
Section 1 - About the Company
  • GlaxoSmithKline Plc - Key Facts
  • GlaxoSmithKline Plc - Key Employees
  • GlaxoSmithKline Plc - Key Employee Biographies
  • GlaxoSmithKline Plc - Major Products and Services
  • GlaxoSmithKline Plc - History
  • GlaxoSmithKline Plc - Company Statement
  • GlaxoSmithKline Plc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Joint Venture
Section 2 - Company Analysis
  • Company Overview
  • GlaxoSmithKline Plc - Business Description
  • Business Segment: Consumer Healthcare
  • Overview
  • Performance
  • Key Stats
  • Business Segment: Pharmaceuticals
  • Overview
  • Performance
  • Key Stats
  • Business Segment: Vaccines
  • Overview
  • Performance
  • Key Stats
  • Geographical Segment: International
  • Performance
  • Geographical Segment: The UK
  • Performance
  • Geographical Segment: US
  • Performance
  • R&D Overview
  • GlaxoSmithKline Plc - Corporate Strategy
  • GlaxoSmithKline Plc - SWOT Analysis
  • SWOT Analysis - Overview
  • GlaxoSmithKline Plc - Strengths
  • GlaxoSmithKline Plc - Weaknesses
  • GlaxoSmithKline Plc - Opportunities
  • GlaxoSmithKline Plc - Threats
  • GlaxoSmithKline Plc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • GlaxoSmithKline Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • GlaxoSmithKline Plc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • GlaxoSmithKline Plc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Mar 23, 2018: GSK Update Regarding Pfizer Consumer Healthcare
  • Mar 19, 2018: The Pistoia Alliance Calls for Greater Life Sciences Collaboration to Build the ‘Lab of the Future’
  • Mar 05, 2018: Local nonprofits make a bigger IMPACT with $40,000 award from GSK in the Triangle region of North Carolina
  • Mar 05, 2018: Local nonprofits make a bigger IMPACT with $40,000 award from GSK in Greater Philadelphia region
  • Feb 23, 2018: GSK, Ministry of Economy, Trade and Industry Superior Health and Good Management Act 2018 (White 500) for 2 consecutive years certified
  • Feb 20, 2018: Scientists find new antimalarial drug targets
  • Feb 07, 2018: GSK delivers improvements in sales, margins and cash flow in 2017
  • Jan 11, 2018: A Novel Rapid Method Produces Superior Blood Stem Cells for Bone Marrow Transplantation
  • Jan 09, 2018: Representative Director and President of GlaxoSmithKline Corporation Personnel notice
  • Dec 06, 2017: GSK welcomes launch of the UK Government’s Life Sciences Sector Deal
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
List of Tables
  • GlaxoSmithKline Plc, Key Facts
  • GlaxoSmithKline Plc, Key Employees
  • GlaxoSmithKline Plc, Key Employee Biographies
  • GlaxoSmithKline Plc, Major Products and Services
  • GlaxoSmithKline Plc, History
  • GlaxoSmithKline Plc, Other Locations
  • GlaxoSmithKline Plc, Subsidiaries
  • GlaxoSmithKline Plc, Joint Venture
  • GlaxoSmithKline Plc, Key Competitors
  • GlaxoSmithKline Plc, Ratios based on current share price
  • GlaxoSmithKline Plc, Annual Ratios
  • GlaxoSmithKline Plc, Annual Ratios
  • GlaxoSmithKline Plc, Annual Ratios
  • GlaxoSmithKline Plc, Interim Ratios
  • GlaxoSmithKline Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • GlaxoSmithKline Plc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • GlaxoSmithKline Plc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • GlaxoSmithKline Plc, Performance Chart (2013 - 2017)
  • GlaxoSmithKline Plc, Ratio Charts
  • GlaxoSmithKline Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • GlaxoSmithKline Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Merck & Co Inc
  • Sanofi
  • Pfizer Inc
  • Amgen Inc
  • Eli Lilly and Co
  • Bristol-Myers Squibb Co
  • AstraZeneca Plc
  • AbbVie Inc
  • Novartis AG
  • Johnson & Johnson
  • F. Hoffmann-La Roche Ltd
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll